IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody
Public ClinicalTrials.gov record NCT01206556. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Duration of Human Papilloma Virus (HPV) Type-Specific Antibody After Administration of Quadrivalent HPV Vaccine (QHPV) to HIV-1 Infected Children Previously Enrolled in IMPAACT P1047
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is being done to evaluate how long the immune response from the Human Papilloma Virus (HPV) vaccine you / your child received persists. The immune response occurred after immunization and is what protects you/your child from HPV disease. You / your child received this vaccine as part of an earlier study (P1047). The vaccine is called Human Papillomavirus Vaccine (QHPV Vaccine, also known as GARDASIL®). The study will check to see if the protective effects (called "antibodies") produced by the vaccine have lasted, and for how long these effects will continue to last. You will not be given any medications or vaccines as part of this follow-up study.
Study identification
- NCT ID
- NCT01206556
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 97 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- Dec 2012 (Actual)
- Completion
- Aug 2013 (Actual)
- Last update posted
- Apr 1, 2015
2010 – 2013
United States locations
- U.S. sites
- 22
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Miller Children's Hospital Long Beach (5093) | Long Beach | California | 90806 | — |
| USC/Los Angeles County Medical Center NICHD CRS (5048) | Los Angeles | California | 90033 | — |
| UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601) | Los Angeles | California | 90095 | — |
| Univ of California, San Diego (4601) | San Diego | California | 92103 | — |
| Univ. of California San Francisco NICHD CRS | San Francisco | California | 94117 | — |
| Univ. of Colorado Denver NICHD CRS (5052) | Aurora | Colorado | 80045 | — |
| Children's National Med. Ctr. Washington DC NICHD CRS (5015) | Washington D.C. | District of Columbia | 20010 | — |
| South Florida CDC Ft. Lauderdale NICHD CRS (5055) | Fort Lauderdale | Florida | 33316 | — |
| Univ of Miami Pediatric/Perinatal HIV/AIDS (4201) | Miami | Florida | 33136 | — |
| Rush University Cook County Hospital NICHD CRS (5083) | Chicago | Illinois | 60612 | — |
| Chicago Children's CRS (4001) | Chicago | Illinois | 60614 | — |
| Children's Hospital of Boston (5009) | Boston | Massachusetts | 02115 | — |
| Boston Medical Center Ped. HIV Program NICHD CRS (5011) | Boston | Massachusetts | 02118 | — |
| WNE Maternal Pediatric Adolescent AIDS CRS (7301) | Worcester | Massachusetts | 01605 | — |
| Wayne State University/Children's Hospital of Michigan NICHD CRS (5041) | Detroit | Michigan | 48201 | — |
| New Jersey Medical School (NJ) (2802) | Newark | New Jersey | 07103 | — |
| New York University NY (5012) | New York | New York | 10016 | — |
| Strong Memorial Hospital, University of Rochester NICHD CRS (5057) | Rochester | New York | 14642 | — |
| SUNY Stony Brook (5040) | Stony Brook | New York | 11794-8111 | — |
| Bronx-Lebanon Hospital (6901) | The Bronx | New York | 10457 | — |
| Jacobi Medical Center Bronx (5013) | The Bronx | New York | 10461 | — |
| Texas Children's Hosp / Baylor Univ (3801) | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01206556, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 1, 2015 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01206556 live on ClinicalTrials.gov.